共查询到20条相似文献,搜索用时 15 毫秒
1.
中国人遗传性痉挛性截瘫spastin基因突变研究 总被引:10,自引:0,他引:10
目的 探讨中国人遗传性痉挛性截瘫(hereditary spastic paraplegia,HSP)spastin基因的突变特点,为该病的基因诊断提供依据。方法 应用聚合酶链反应—单链构象多态性(PCR—single strand conformation polymorphism,PCR—SSCP)结合DNA序列分析方法,对22个常染色体显性遗传HSP家系的先证者和9例散发性HSP患者的spastin基因进行研究,对发现异常SSCP条带的家系内成员进行突变研究。结果 在22例常染色体显性遗传HSP家系的先证者和9例散发性HSP患者中发现异常SSCP条带6例,进行DNA序列分析,共发现3种spastin基因突变,为外显子8的T1258A和A1293G,外显子14的1667delACT或1668delCTA或1669delTAC,均未见报道,突变位点均位于spastin基因功能区域,其中两个家系存在同一种突变(T1258A),各突变家系内患者存在同样的异常SSCP条带。结论 中国人遗传性痉挛性截瘫患者存在spastin基因突变,该基因在中国人常染色体显性遗传的遗传性痉挛性截瘫家系中的突变率较低(18.2%),点突变是主要的突变形式,外显子8可能是中国人spastin基因的突变热点。 相似文献
2.
遗传性痉挛性截瘫是一种具有高度临床和遗传异质性的神经系统变性性疾病.现已定位35型,17型致病基因已被克隆.其中呈显性遗传的第4型和呈隐性遗传的第7型是较常见的亚型.它们的致病基因分别编码蛋白spastin与paraplegin,二者同属于AAA ATP酶家族.现对研究较多的这两型进行综述,并借此反映该病近年来的研究进展. 相似文献
3.
遗传性痉挛性截瘫11型研究进展 总被引:2,自引:0,他引:2
遗传性痉挛性截瘫是一种遗传性、神经退行性变的疾病,具有明显的遗传异质性,遗传形式多样.遗传性痉挛性截瘫11型是隐形遗传尤其是合并有胼胝体发育不良患者中最常见的类型,现就近几年来该病的研究进展,从遗传性痉挛性截瘫11型的基因定位和克隆,基因突变情况及其临床表现,诊断与鉴别诊断、发病机制等方面进行全面的介绍. 相似文献
4.
Autosomal dominant familial spastic paraplegia: report of a large New England family 总被引:1,自引:0,他引:1
W. C. Cooley E. Rawnsley G. Melkonian C. Moses D. McCann B. Virgin J. Coughlan J. B. Moeschler 《Clinical genetics》1990,38(1):57-68
A large New England family with autosomal dominant familial spastic paraplegia is described. In a pedigree of 173 individuals, 71 affected individuals are identified. Seventeen cases examined by the authors are described with regard to the natural history of FSP in this family. A staging system for following progress and planning interventions is proposed. Three illustrative cases are presented. In this family, FSP is found to have a homogeneous clinical course with nearly complete penetrance. Onset occurs at or before 3 years of age with involvement limited to the lower extremities. After the initial onset, no significant progression was noted. Early aggressive habilitative care may result in more functional ambulation. 相似文献
5.
Ivanova N Löfgren A Tournev I Rousev R Andreeva A Jordanova A Georgieva V Deconinck T Timmerman V Kremensky I De Jonghe P Mitev V 《Clinical genetics》2006,70(6):490-495
Hereditary spastic paraplegia (HSP) is an extremely heterogeneous group of neurodegenerative disorders affecting the longest axons in the central nervous system. The most common genetic form accounting for about 40% of the autosomal-dominant HSP (ADHSP) cases is spastin gene, SPG4. We performed mutation screening of the spastin gene on 36 unrelated HSP patients from three different ethnic groups (Bulgarian, Turks and Gypsies) and found four new mutations and one already reported. The phenotype-genotype correlations in Bulgarian SPG4 patients showed a great difference in the age at disease onset between patients with missense mutations and those harboring deletions and splice-site mutations. Our study is the first to present corroborative clinical data in favor of the general hypothesis that the clinical course of the disease is related to the type of the spastin mutation. The clinical and genealogical findings in Bulgarian SPG4 patients suggest that a positive family history for inheritance as an autosomal-dominant trait is a strong indication for spastin mutation screening. 相似文献
6.
Xianling Wang Xu-Ying Li Yueshan Piao Guobin Yuan Yicong Lin Hai Chen Zhanjun Wang Cunjiang Li Chaodong Wang 《American journal of medical genetics. Part A》2022,188(1):237-242
Hartnup disease cases were rare, and the genotype–phenotype correlation was not fully understood. Here we reported two unrelated young men diagnosed as Hartnup disease, who carried novel compound heterozygote mutations in the SLC6A19 gene and presented with new phenotypes. Other than intermittent encephalopathy and photosensitive rashes, they displayed symptoms and signs of spastic paraplegia and severe peripheral nerve damages. Magnetic resonance imaging showed mild bilateral cerebellar atrophy and thinning of the thoracic spinal cord. Electromyogram detected mixed sensorimotor polyneuropathy in lower limbs. Sural nerve biopsy and pathological study indicated the moderately reduced neural fibers in the periphery nerves. Urinary amino acid analysis showed increased levels of multiple neutral amino acids. Moreover, muscle strengths in the lower limbs and the walking ability have been improved in both cases (MRC 3/5 to 4/5 in Patient 1; walking distance elongated from 50 to 100 m in Patient 2) after the treatment with oral nicotinic acid and intravenous injection of multiple amino acids. Exome sequencing revealed and confirmed the existence of the novel compound heterozygous SLC6A19 mutations: c.533G>A (p.Arg178Gln) and c.1379-1G>C mutations in patient1, and c.1433delG (p.Gly478AlafsTer44) and c.811G>A (p.Ala271Thr) in patient 2. Taken together, these findings expanded the clinical, neuroimaging, pathology, and genetic spectrum of Hartnup disease. However, the co-existence of HSP and peripheral neuropathy was only inferred based on clinical observations, and pathological and molecular studies are needed to further dissect the underlying mechanisms. 相似文献
7.
一个遗传性痉挛性截瘫家系的临床特点与spastin基因突变分析 总被引:1,自引:0,他引:1
目的探讨遗传性痉挛性截瘫(hereditary spastic paraplegia,HSP)一家系的临床特点及其与spastin基因突变关系。方法对整个家系进行详细的临床检查,先证者和家系内另两例患者进行了肌电图检查,先证者还进行了胸髓核磁共振检查。应用聚合酶链反应结合DNA序列分析方法,检测该家系中先证者和其父亲spastin基因的突变情况。结果家族中所有患者具有遗传性痉挛性截瘫的典型表现,先证者胸髓核磁共振成像显示胸髓明显萎缩,PCR-DNA序列分析患者spastin基因的17个外显子均未发现有异常的突变。结论该HSP家系的患者具有典型的临床表现,并非spastin基因外显子突变所致。 相似文献
8.
Hereditary spastic paraplegia (HSP) is rarely inherited in an X-linked recessive mode in pure and complicated forms. Recently, molecular linkage studies have suggested that these variant X-linked HSP conditions result from locus heterogeneity. In this paper we report on the clinical and linkage analysis of a kindred with complicated X-linked HSP. The finding in this family of a map location of the putative HSP gene in the same region as the documented for the pure HSP gene provides evidence that allelic mutations might also be responsible for the variable phenotype encountered in these X-linked disorders. 相似文献
9.
目的探讨微卫星标记D15S971-D15S1012区间内全部10个已知基因是否为所收集的遗传性痉挛性截瘫伴胼胝体发育不良(hereditary spastic paraplegia with thin corpus callosum,HSP-TCC)家系的致病基因。方法应用聚合酶链反应、DNA直接测序和疾病表型共分离研究,对收集的5个HSP-TCC家系患者进行染色体15q13-15微卫星标记D15S971和D15S1012区间内10个已知基因(AK128197、MGC14798、HH114、MEIS2、MGC35118、SPRED1、AK128458、FLJ38426、RASGRP1、AK093014)突变分析。结果5个HSP-TCC家系的10个基因突变分析未发现致病突变,仅发现13种多态,其中2个为新发现的多态。结论经突变分析基本排除微卫星标记D15S971-D15S1012区间内全部10个已知基因为所收集的5个HSP-TCC家系的致病基因。 相似文献
10.
GPT2 mutations cause developmental encephalopathy with microcephaly and features of complicated hereditary spastic paraplegia
下载免费PDF全文
![点击此处可从《Clinical genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H. Hengel R. Keimer W. Deigendesch A. Rieß H. Marzouqa J. Zaidan P. Bauer L. Schöls 《Clinical genetics》2018,94(3-4):356-361
Various genetic defects can cause intellectual and developmental disabilities (IDDs). Often IDD is a symptom of a more complex neurodevelopmental or neurodegenerative syndrome. Identifying syndromic patterns is substantive for diagnostics and for understanding the pathomechanism of a disease. Recessive glutamate pyruvate transaminase (GPT2) mutations have recently been associated with IDD in 4 families. Here, we report a novel recessive GPT2 stop mutation p.Gln24* causing a complex IDD phenotype in a homozygous state in 5 patients from 2 consanguineous Arab families. By compiling clinical information of these individuals and previously described GPT2 patients a recognizable neurodevelopmental and potentially neurodegenerative phenotype can be assigned consisting of intellectual disability, pyramidal tract affection with spastic paraplegia, microcephaly and frequently epilepsy. Because of the consistent presence of pyramidal tract affection in GPT2 patients, we further suggest that GPT2 mutations should be considered in cases with complex hereditary spastic paraplegia. 相似文献
11.
Chen S Song C Guo H Xu P Huang W Zhou Y Sun J Li CX Du Y Li X Liu Z Geng D Maxwell PH Zhang C Wang Y 《Human mutation》2005,25(2):135-141
Hereditary spastic paraplegia (HSP) is a neurodegenerative disease characterized by lower-limb spasticity, hyperreflexia, progressive spastic gait abnormalities, and an extensor-plantar response. It is genetically very heterogeneous, with 28 Human Genome Organisation (HUGO)-approved IDs in the database (last search: August 8, 2004). Following the identification of the SPG6 gene, NIPA1, we have identified two novel mutations, c.316G>C and c.316G>A, in two independent Chinese families linked to the SPG6 locus. These two mutations would cause a p.G106R substitution, and cosegregated with the disease. Structural predictions suggest that p.G106 is located in the third transmembrane domain of the protein, and that the mutant p.G106R disrupts this structure, causing the intramembrane loop to descend into the cytoplasm. Our results identify two novel mutations responsible for HSP and suggest that c.316 of theNIPA1 gene may be a mutational hotspot. 相似文献
12.
Sauter S Miterski B Klimpe S Bönsch D Schöls L Visbeck A Papke T Hopf HC Engel W Deufel T Epplen JT Neesen J 《Human mutation》2002,20(2):127-132
Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Autosomal dominant hereditary spastic paraplegia 4 linked to chromosome 2p (SPG4) is the most common form of autosomal dominant hereditary spastic paraplegia. It is caused by mutations in the SPG4 gene encoding spastin, a member of the AAA protein family of ATPases. In this study the spastin gene of HSP patients from 161 apparently unrelated families in Germany was analyzed. The authors identified mutations in 27 out of the 161 HSP families; 23 of these mutations have not been described before and only one mutation was found in two families. Among the detected mutations are 14 frameshift, four nonsense, and four missense mutations, one large deletion spanning several exons, as well as four mutations that affect splicing. Most of the novel mutations are located in the conserved AAA cassette-encoding region of the spastin gene. The relative frequency of spastin gene mutations in an unselected group of German HSP patients is approximately 17%. Frameshift mutations account for the majority of SPG4 mutations in this population. The proportion of splice mutations is considerably lower than reported elsewhere. 相似文献
13.
14.
Katherine J. Dick Matthias Eckhardt Coro Paisán‐Ruiz Aisha Alkhayat Alshehhi Christos Proukakis Naomi A. Sibtain Helena Maier Reza Sharifi Michael A. Patton Wafa Bashir Roshan Koul Sandy Raeburn Volkmar Gieselmann Henry Houlden Andrew H. Crosby 《Human mutation》2010,31(4):E1251-E1260
Hereditary spastic paraplegia (HSP) describes a heterogeneous group of inherited neurodegenerative disorders in which the cardinal pathological feature is upper motor neurone degeneration leading to progressive spasticity and weakness of the lower limbs. Using samples from a large Omani family we recently mapped a gene for a novel autosomal recessive form of HSP (SPG35) in which the spastic paraplegia was associated with intellectual disability and seizures. Magnetic resonance imaging of the brain of SPG35 patients showed white matter abnormalities suggestive of a leukodystrophy. Here we report homozygous mutations in the fatty acid 2‐hydroxylase gene (FA2H) in the original family used to define the SPG35 locus (p.Arg235Cys) as well as in a previously unreported Pakistani family with a similar phenotype (p.Arg53_Ile58del). Measurement of enzyme activity in vitro revealed significantly reduced enzymatic function of FA2H associated with these mutations. These results demonstrate that mutations in FA2H are associated with SPG35, and that abnormal hydroxylation of myelin galactocerebroside lipid components can lead to a severe progressive phenotype, with a clinical presentation of complicated HSP and radiological features of leukodystrophy. © 2010 Wiley‐Liss, Inc. 相似文献
15.
16.
E Sánchez‐Ferrero E Coto C Beetz J Gámez AI Corao M Díaz J Esteban E del Castillo G Moris J Infante M Menéndez SI Pascual‐Pascual A López de Munaín MJ Garcia‐Barcina V Alvarez 《Clinical genetics》2013,83(3):257-262
Sánchez‐Ferrero E, Coto E, Beetz C, Gámez J, Corao A, Díaz M, Esteban J, del Castillo E, Moris G, Infante J, Menéndez M, Pascual‐Pascual SI, López de Munaín A, Garcia‐Barcina MJ, Alvarez V on behalf of the Genetics of Spastic Paraplegia study group. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Mutations in the SPG7 gene were initially reported in patients with autosomal recessive hereditary spastic paraplegia (HSP). Recent works suggested a dominant effect for some SPG7 mutations. To characterize the SPG7 mutational spectrum in a large cohort of Spanish HSP patients, we sequenced the whole SPG7 gene in a total of 285 Spastic Paraplegia patients. Large gene rearrangements were also ascertained in some patients. We found a total of 14 SPG7 mutations (12 new) in 14 patients; 2 were large deletions. All the mutation carriers had an adult onset age but only five (35%) had a complicated phenotype. We identified a single mutation in 13 patients. Familial analysis suggested a dominant inheritance for one (p.Leu78*) of these mutations. Carriers of the rare p.A510V variant were significantly more frequent in patients vs healthy controls (3% vs 1%), suggesting a pathogenic role for this SPG7 variant. We reported a high frequency of patients with only one SPG7 mutation, and a putative pathogenic role for the p.A510V variant. 相似文献
17.
Ki CS Lee WY Han DH Sung DH Lee KB Lee KA Cho SS Cho S Hwang H Sohn KM Choi YJ Kim JW 《Journal of human genetics》2002,47(9):473-477
Hereditary spastic paraplegia (HSP) is a group of clinically and genetically heterogeneous neurodegenerative disorders characterized
by slowly progressive spasticity and weakness of the lower extremities. Among eight loci linked with autosomal-dominant (AD)-HSP,
the SPG4 locus on chromosome 2p22 accounts for about 40% of all patients. Recently, mutations in a new member of the AAA protein family,
called spastin, have been identified as responsible for SPG4-linked AD-HSP. Here, we describe a novel missense mutation (c.1031T>A; I344K) in exon 7 of the SPG4 gene identified in a Korean family with typical clinical features of pure AD-HSP. The mutation affects the third amino acid
of the highly conserved AAA cassette domain, which is the most fore part of the domain altered by a missense mutation reported
so far. Clinical presentations of affected individuals carrying the I344K mutation were not different from those of pure AD-HSP
with SPG4 mutations reported previously. However, it is noteworthy that neither urinary dysfunction nor involvement of upper extremities
was noticed in this family. To our knowledge, this is the first report of genetically confirmed AD-HSP in Korea.
Received: February 20, 2002 / Accepted: May 21, 2002 相似文献
18.
Mengyuan Liu Bing Li Xiaona Wang Dongxiao Li Zhenhua Xie Yuke Li Yang Gao Baiyun Chen Huichun Zhang Yanli Wang Chao Gao 《Annals of human genetics》2023,87(4):158-165
Objective
The objective of this study was to investigate the pathogenesis and inheritance pattern of a Chinese Han family with hereditary spastic paraplegia and to retrospectively analyze the characteristics of KIF1A gene variants and related clinical manifestations.Methods
High-throughput whole-exome sequencing was performed on members of a Chinese Han family with a clinical diagnosis of hereditary spastic paraplegia, and the sequencing results were validated by Sanger sequencing. Deep high-throughput sequencing was performed on subjects with suspected mosaic variants. The previously reported pathogenic variant loci of the KIF1A gene with complete data were collected, and the clinical manifestations and characteristics of the pathogenic KIF1A gene variant were analyzed.Results
A pathogenic heterozygous variant located in the neck coil of the KIF1A gene (c.1139G>C, p.Arg380Pro) was identified in the proband and four additional members of the family. It was derived from the de novo low-frequency somatic-gonadal mosaicism of the proband's grandmother and had a rate of 10.95%.Interpretation
This study helps us to better understand the pathogenic mode and characteristics of mosaic variants, and to understand the location and clinical characteristics of pathogenic variants in KIF1A. 相似文献19.
BN Smith S Bevan C Vance P Renwick P Wilkinson C Proukakis F Squitieri A Berardelli TT Warner E Reid and CE Shaw 《Clinical genetics》2009,75(5):485-489
Mutation of the atlastin gene ( SPG3A ) is responsible for ∼10% of autosomal dominant hereditary spastic paraplegia (AD-HSP) cases. The goal of this study was to identify novel disease causing atlastin mutations. Atlastin nucleotide variations were detected by direct sequencing of all 14 exons in 70 autosomal dominant (AD), 16 single sibship and 14 sporadic spastic paraplegia patients. Six mis-sense mutations (four of which were novel) were identified in six unrelated AD-HSP kindreds in exons 4, 7 and 8 of the atlastin gene. One kindred with a novel mutation showed variability in clinical phenotype and age of onset. Mutations are predicted to decrease GTPase activity, cause morphological abnormalities of the endoplasmic reticulum and prevent maturation of the Golgi complex resulting in impaired vesicle trafficking. Our study significantly adds to the spectrum of mutations and clinical phenotype of SPG3A . We advocate that all spastin mutation negative AD-HSP kindreds should be screened for pathogenic atlastin mutations regardless of age of onset or phenotypic complexity. 相似文献
20.
Novel homozygous missense mutation in NT5C2 underlying hereditary spastic paraplegia SPG45
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rachel Straussberg Alexandros Onoufriadis Osnat Konen Yasmin Zouabi Lior Cohen John Y.W. Lee Chao‐Kai Hsu Michael A. Simpson John A. McGrath 《American journal of medical genetics. Part A》2017,173(11):3109-3113